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Testosterone is a hormone that has been shown to confer neuroprotection from different
insults affecting the central nervous system (CNS). Testosterone induces this protection
by different mechanisms that include the activation of anti-apoptotic pathways that are
directly implicated in neuronal survival. However, little attention has been devoted to its
actions on glial cells. In the present study, we have assessed whether testosterone exerts
protection in a human astrocyte cell model, the T98G cells. Our results indicate that
testosterone improves cell survival and mitochondrial membrane potential and reduces
nuclear fragmentation and reactive oxygen species (ROS) generation. These effects were
accompanied by a positive regulation of neuroglobin, an oxygen-binding and sensor
protein, which may serve as a regulator of ROS and nitrogen reactive species (NOS),
and these protective effects of testosterone may be at least in part mediated by estradiol
and DHT. In conclusion, these findings suggest that astroglia may mediate some of the
protective actions of testosterone in the brain upon pathological conditions.
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INTRODUCTION
Testosterone, a gonadal hormone, modulates aggressive and sexual behavior (Christiansen, 2001),
has anxiolytic and antidepressant-like effects (Carrier et al., 2015), affects cognition (Cherrier,
2005), and regulates synaptic plasticity in the brain (Hatanaka et al., 2015). Moreover, testosterone
has been shown to prevent neuronal cell death, to improve memory after damage (Fanaei et al.,
2014), and to regulate the activation and reactivity of glial cells upon brain injury (Barreto et al.,
2007). The neuroprotective actions of testosterone may in part explain that the decrease in its
plasma levels with aging is associated with an increase in neurodegenerative diseases (Bialek et al.,
2004; Gold and Voskuhl, 2006; Rosario et al., 2011; Barron and Pike, 2012; Khasnavis et al., 2013).
Furthermore, testosterone may be converted into estradiol by aromatase, or dihydrotestosterone
(DHT) via 5α-reductase, and part of the protective effects of testosterone might be due to its
metabolites (Barreto et al., 2007).
Improvement of mitochondrial function may be one of the mechanisms involved in the
protective actions of testosterone in the brain. For example, testosterone enhances the functional
recovery in animals subjected to cerebral ischemia by promoting the increase of BDNF, antioxidant
defense/activity and neurogenesis (Chisu et al., 2006; Fanaei et al., 2014). Similarly, chronic
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treatment with testosterone modulated the Nrf2-Are activation
(Zhang et al., 2013), improved behavior in aged rats (Zhang et al.,
2013), and decreased oxidative stress and cell damage induced by
3-nitropropionic acid in ovariectomized rats (Tunez et al., 2007).
Accordingly, testosterone suppression is associated to high brain
susceptibility to oxidative damage (Son et al., 2016), accelerated
neuronal death (Ota et al., 2012), augmented malondiadehyde
(MDA) levels, increased Bax immunoreactivity, and decreased
expression of mitochondrial enzymes (Meydan et al., 2010). This
decrease is accompanied by a downregulation of mitochondrial
gene expression and decline in PGC-1α (Hioki et al., 2014). More
recently, it has been reported that neuroglobin (Ngb) is involved
in the protective actions of estradiol and might be implicated
in the anti-inflammatory and neuroprotective properties of this
hormone in astrocytes and neurons (De Marinis et al., 2010,
2013a,b). However, it is unknown whether testosterone might
exert its effects through modulation of Ngb in astrocytes upon
metabolic damage.
MATERIALS AND METHODS
T98G Cell Culture
T98G cell line was used as an astrocytic cell model system
(ATCC CRL-1690) (Gasque et al., 1996; de Joannon et al., 2000;
Mao et al., 2006). Cells were maintained under exponential
growth in Dulbecco’s modified Eagle’s medium (DMEM)
(LONZA,Walkersville, USA), containing 10% fetal bovine serum
(FBS) (LONZA, Walkersville, USA), and 10U penicillin/10 µg
streptomycin/25 ng amphotericin (LONZA, Walkersville, USA).
The medium was changed three times a week. Cultures were
incubated at 37◦C in a humidified atmosphere containing 5%
carbon dioxide and 95% oxygen. Cells were seeded in 96-
well plates for cell death measurement, 12-well plates for flow
cytometry determinations and 24-well plate for tetra-methyl
rhodamine methyl ester (TMRM) and immunofluorescence
measurements.
Drug Treatments
Once the cells were seeded in the multi-well plates, the
cultured media was replaced with DMEM supplemented with
1% fetal bovine serum for 12 h (LONZA, Walkersville, USA).
Twenty-four hours before glucose deprivation some cell cultures
were incubated in DMEM serum-free medium containing
1, 10, or 100 nM testosterone, 10 nM estradiol or 10 nM
DHT. Testosterone was dissolved in 0.01%, DMSO as stock
solution at 5µM, while estradiol and DHT were dissolved in
0.0001% ethanol and 0.0001%methanol, respectively, and further
dilutions were made using serum-free culture medium.
Glucose Deprivation
Glucose deprivation was performed as previously reported (Avila
Rodriguez et al., 2014). Briefly, before glucose deprivation, cells
were washed three times with glucose-free, balanced salt solution
(BSS 0) containing in mM: NaCl, 116; CaCl2, 1.8; MgSO4,
(7.H2O) 0.8; KCl, 5.4; NaH2PO4, 1; NaHCO3, 14.7, and 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 10; pH
7.4. Subsequently, cells were incubated with BSS0 and transferred
to the incubator for 24 h. The wash controls cells had their
medium changed to BSS5, which was identical to BSS0, but
supplemented with 5.5 mM glucose.
Determination of Viability and Nuclear
Fragmentation
Cells were seeded into 96-wells plates in DMEM culture medium
containing 10% FBS at seeding density of 10,000 cells per well and
incubated for 2–3 days until they reach confluence. Subsequently,
cells were treated according to different experimental paradigms.
Viability was determined by propidium iodide (PI) assay and
assessed by flow cytometry. Briefly, cells were seeded into 24-
wells plates in DMEM culture medium containing 10% bovine
fetal serum at seeding density of 30,000 cells per well, incubated
for 2–3 days until they reach confluence. Then, cells were
subjected to drug and injury conditions. Once the treatments
were finished, cells were washed in PBS and detached with trypsin
(Trypsin/EDTA 500 mg/L:200 mg/L; LONZA, Walkersville,
USA). Then, cells were stained with PI dissolved in PBS at a
final concentration of 10µg/ml for 10min. Subsequently cells
were analyzed in a Guava EasyCyte
TM
(Millipore, Billerica,
Massachusetts, USA) cytometer. Each assay was performed with
a minimum of six replicates for each condition. The experiment
was repeated 3 times.
Nuclear fragmentation was determined by Hoechst 33258
staining. After exposure to glucose deprivation and different
experimental paradigms, cells were washed three times in
phosphate-buffered saline and fixed for 20 min in 4%
formaldehyde at room temperature. Subsequently, cells were
washed and labeled with Hoechst 33258 (5 mg/ml; Invitrogen)
for 15 min. Cell nuclei were observed and photographed using an
inverted fluorescence microscope Olympus IX-53. The number
of fragmented nuclei was determined in at least eight randomly
selected areas (0.03 mm2) within series of wells from each
experimental group. The experiment was repeated 3 times. Data
were expressed as a percentage of nuclear fragmented cells
relative to the value in control cultures.
Determination of Reactive Oxygen Species
(ROS)
Reactive oxygen species levels were evaluated by flow cytometry
as previously described (Avila Rodriguez et al., 2014). Briefly,
cells were seeded at a density of 75,000 per well into 12-well
plates in DMEM culture medium containing 10% FBS and then
were treated according to each experimental paradigm in the
next day. To measure the effect of testosterone on superoxide
(O2−) or peroxide hydrogen levels (H2O2), cells were treated
in the dark for 30 min at 37◦C with 10 mM dihydroethidium
(DHE; Sigma) or 10 µmol/L 2′,7′-dichlorofluorescin diacetate
(DCFDA) staining, respectively. Then, cells were washed in PBS
and detached with trypsin solution (Trypsin/EDTA 500mg/L:200
mg/L; LONZA, Walkersville, USA) for flow cytometry analysis.
Cells were analyzed in a Guava EasyCyte
TM
(Millipore, Billerica,
Massachusetts, USA) cytometer. Each assay was performed with
a minimum of six replicates for each condition. The experiment
was repeated 3 times.
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Determination of Mitochondrial Membrane
Potential
Mitochondrial membrane potential was evaluated using
Tetramethyl Rhodamine Methyl Ester (TMRM) and assessed
by flow cytometry and qualitative images were assessed using
fluorescence microscope. For flow cytometry analysis, cells
were seeded at a density of 75,000 cells per well into 12-well
plates and treated according to each experimental paradigm
in the next day. After glucose deprivation for 24 h, cells were
loaded in the dark with 500 nM TMRM at 37◦C for 20min.
Thereafter, cells were washed with PBS to eliminate all the
non-sequestered dye, and detached using trypsin. Then the cells
were analyzed by flow cytometry. As experimental control, we
used the uncoupler CCCP (Sigma-Aldrich V0627; 100 nM) to
dissipate the membrane potential and define the baseline for
analysis of mitochondrial potential. Each assay was performed
with a minimum of six replicates for each condition. Each
experiment was repeated at least 3 times.
For TMRM fluorescence imaging, cells were seeded at a
density of 30,000 cells per well into 24-well plates in DMEM
culture medium containing 10% FBS, and subjected to each
experimental paradigm in the next day. Once finished the
treatments, cells were subjected to glucose deprivation and then
incubated with TMRM for 30min. Finally, cells were washed
with PBS and photographed in an Olympus IX-53 fluorescence
microscope.
Determination of Mitochondrial Mass
Mitochondrial mass was evaluated using Nonyl acridine orange
(NAO). NAO is a cell-permeate, cationic fluorescent dye
sequestered by activemitochondria. After 24 h of treatments, cells
were loaded in the dark with 5µM NAO at 37◦C for 20min.
Thereafter, cells were washed with PBS to eliminate all non-
sequestered dye. Mitochondrial mass was further evaluated by
flow cytometry in a GuavaR EasyCyte
TM
(Millipore) cytometer.
Estimation of Cellular Mean Fluorescence
Intensity
The analysis of cellular fluorescence for was performed using
ImageJ version 1.47v (Hartig, 2013). The microphotographs were
loaded and background signals were eliminated from the images.
Subsequently, 20 cells were randomly selected using a numbered
grid in each microphotograph. The mean fluorescence value of
the 20 cells was determined in eight microphotographs for each
treatment using the Measure algorithm of ImageJ and selecting
each cell manually via ROI’s (Regions of Interest) Management.
Cells were analyzed in an area of 0.03mm2. There were no
variations in the conditions of the image processing. Each assay
was performed with a minimum of six replicate wells for each
condition and experiments were repeated three times.
Neuroglobin Assessment
Ngb1 was assessed by immunofluorescence following the
experimental treatments previously described. For neuroglobin
immunofluorescence, cells were cultured on 24-wells plates, and
at the end of treatments, cells were washed in PBS and fixed
with 4% paraformaldehyde for 20 min at room temperature.
Subsequently, cells were treated for 3min in 0.1% Triton X-100 in
tris buffer saline (TBS) with 2% BSA. After, this permeabilization
step, cells were washed with PBS, blocked with 2% BSA and
incubated overnight at 4◦C with mouse anti-Ngb1 antibody
(Abcam R© ab37258; diluted 1:50). Then, cells were washed three
times for 5 min with TBS and incubated for 45 min at room
temperature with Dylight conjugated-488 anti-mouse secondary
antibody, diluted 1:1000. Cells were then washed three times,
and photographed in a fluorescence Olympus IX-53 inverted
microscope.
Statistical Analysis
Data obtained was tested for normal distribution by
Kolmogorov–Smirnov test and homogeneity of variance by
Levene’s test. Then, data were examined by analysis of variance,
followed by Dunnet’s post hoc test for comparisons between
controls and treatments and Tukey’s post hoc test for multiple
comparisons between the means of treatments and timepoints.
Data are presented as mean ± SEM. A statistically significant
difference was defined at p< 0.05.
RESULTS
Testosterone Increased Cell Viability and
Preserved Morphology in Glucose
Deprived Cells
Initially, optimal experimental conditions of testosterone
treatment upon glucose deprivation (GD) were assessed. Cells
were pretreated with testosterone at different concentrations
for 24 h and subsequently subjected to GD for 18 h. Cells
pretreated with 1, 10, and 100 nM testosterone showed a 65.29%
(p < 0.0001), 83.00% (p < 0.0001), and 42.87% increase in cell
viability by PI assay when compared to BSS0 cells, respectively,
(Figure 1A). Qualitative analysis for PI fluorescence confirmed
the results (Figures 1B–D). Based on these results, the 10 nM
dose of testosterone was used in further experiments.
Cell viability andmorphology are tightly related, and increases
in oxidative stress usually induce noticeable morphological
changes. In agreement with the observed changes in cell viability,
GD cells showed smaller cell bodies and less cellular processes
than control cells (Figure 1E). Testosterone (10 nM) preserved
cell morphology even in cells treated with medium without
glucose (BSS0, Figure 1F).
Testosterone Prevented Nuclear
Fragmentation and Chromatin
Condensation in GD Cells
To further assess the protective effect of testosterone, we studied
its effect on nuclear fragmentation and nuclear condensation
in GD cells using Hoescht 33258 staining. Figure 2 shows that
GD for 18 h increased nuclear fragmentation and chromatin
condensation by 48.50% in T98G cells when compared to control
(BSS5, Figure 2, p < 0.0001). GD dramatically induced nuclear
fragmentation and chromatin condensation, which wasmarkedly
reduced to 4.73% in the presence of testosterone (p< 0.0001).
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FIGURE 1 | Testosterone decreases glucose deprivation induced cell
death. T98G cells were pre-treated for 24 h with several concentrations of
Testosterone and then exposed to GD (BSS0) for 18 h and cell viability was
assessed by PI staining (A–D). Data are represented as mean ± SEM of 4
independent experiments. Mean ± SEM values are as follows: BSS0 (43.90 ±
3.247); Testosterone + BSS0 (1 nM 65.29 ± 1.49; 10 nM, 83.00 ± 3.162; 100
nM 42.87 ± 2.621) normalized respect to BSS5 (control). Testosterone
diminishes morphological alterations induced by glucose deprivation. (E–G)
Representative microphotographs showing the morphology of cells exposed to
BSS0 (E), 10 nM Testosterone+ BSS0 (F), and BSS5 (G). Scale bar 100 µm.
Testosterone Protected Mitochondria by
Reducing Reactive Oxygen Species
Production and Improving Mitochondrial
Membrane Potential and Mass
Glucose deprivation induces the generation of ROS, especially
superoxide anions and hydrogen peroxide. Our results show
that GD augmented O2-production, and that testosterone
significantly reduced superoxide generation (Figures 3A–C,
p< 0.0004). A similar effect of testosterone in reducing hydrogen
peroxide (H2O2) production was also observed. Figure 3D shows
that H2O2 levels increased in the early hours after the insult,
reaching the highest level after 6 h and decreasing thereafter.
Fluorescence levels of H2O2 were 396, 244, 166, and 138 at 6, 9,
12, and 18 h, respectively. Testosterone significantly attenuated
H2O2 levels at 6 h (p < 0.0368), 9 h (p < 0.0047), 12 h (p <
0.0319), and 18 h (p< 0.0484) in comparison to cells treated with
BSS0 alone (Figure 3D).
The mitochondrial membrane potential (1ψm) was
assessed using TMRM staining by flow cytometry. Figure 4
shows differences in 1ψm in cells exposed to BSS0
(Figure 4A), BSS5 (Figure 4B), and Testosterone + BSS0
(Figure 4C). Cells pre-treated with testosterone maintained
mitochondrial membrane potential similar to that of BSS5
levels. To observe the kinetics of membrane potential in
FIGURE 2 | Testosterone reduces nuclear fragmentation following
glucose deprivation. The panel shows representative microphotographs of
T98G cells exposed to BSS0 (A), BSS5 (B), and Testosterone + BSS0 (C).
Scale bar 100 µm. The bar graph shows the percentage of cells with
fragmented nuclei. Data are represented as mean ± SEM of 3 independent
experiments. Mean ± SEM values are as follows: BSS5 (1.193 ± 0.7062);
BSS0 (48.50 ± 2.929), Testosterone + BSS0 (4.30 ± 2.439).
different time points, the analysis was performed at 3, 6,
9, 12, and 18 h after GD. The mitochondrial membrane
potential was preserved during the first 3 h of GD with no
significant changes. However, significant loss of 1ψm was
observed at 12 (p < 0.0004) and 18 h (p < 0.0003) compared
to BSS5. However, testosterone preserved mitochondrial
membrane potential at 12 (p < 0.0012) and 18 h (p < 0.0059;
Figure 4D).
Similar results were observed when staining cells for NAO
(nonyl acridine orange) to assess mitochondrial mass. Qualitative
results suggested that GD may induce a loss of mitochondrial
mass (Figure 5A) and that testosterone reduced this effect
(Figure 5C). Quantitative studies using flow cytometry for
NAO confirmed these observations. GD significantly reduced
mitochondrial mass (p < 0.0009) in comparison to BSS5, and
testosterone significantly increasedNAOfluorescence in GD cells
(p< 0.0306).
Testosterone Increases Neuroglobin
Expression in GD Cells
Neuroglobin is a protein suspected to play an important role
in detoxifying ROS and neuroprotection against different types
of insults (De Marinis et al., 2010, 2013a,b). Because of its
potential importance for cell survival after GD, neuroglobin
immunoreactivity was assessed by immunocytochemistry. The
results showed that GD significantly induced the expression
of neuroglobin (Figure 6A) that was significantly different
from that of control values (BSS5, Figure 6B, p < 0.0001).
Interestingly, testosterone was able to induce neuroglobin
expression in GD cells when compared to GD only (p < 0.0001;
Figure 6C).
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FIGURE 3 | Testosterone reduces reactive oxygen species production
at 18 h of glucose deprivation. Representative microphotographs of DHE
staining in T98G cells exposed to BSS0 (A), BSS5 (B), Testosterone + BSS0
(C). Scale bar 100 µm. The bar graph shows the values of DHE fluorescence.
Data are represented as mean ± SEM of 3 independent experiments. Mean ±
SEM values are as follows: BSS0 (157.5 ± 2.994), Testosterone + BSS0
(131.2 ± 3.995) normalized respect to BSS5 (control). (D) Kinetics of hydrogen
peroxide production (DCFDA staining) using flow cytometry over time following
glucose deprivation only and treated with testosterone at 10 nM. Mean ± SEM
statistically significant values are as follows: 6 h, BSS5 (59.67 ± 6.927), BSS0
(396.0 ± 52.16), Testosterone+ BSS0 (261.5 ± 16.04); 9 h, BSS5 (128.9 ±
12.51), BSS0 (244.3 ± 17.67), Testosterone+ BSS0 (136.7 ± 6.667); 12 h,
BSS5 (79.00 ± 6.646), BSS0 (137.6 ± 15.14), Testosterone + BSS0 (69.00 ±
17.69); 18 h, BSS5 (50.00 ± 4.550), BSS0 (166.0 ± 12.38), Testosterone +
BSS0 (112.7 ± 14.38).
Estradiol and DHT Protect Mitochondria in
Glucose-Deprived Cells
To determine whether testosterone might exert neuroprotective
effects through its metabolites, cells were pre-treated with
either 10 nM estradiol or 10 nM DHT before GD insult.
Our results indicated that estradiol improved cell viability
(Figure 7A, p < 0.0001) and mitochondrial membrane potential
(p < 0.0001), reduced O2-production (Figure 7C, p < 0.0002),
and H2O2 levels (Figure 7D, p < 0.0164) and significantly
increased mitochondrial mass (Figure 7E, p < 0.0011) in
comparison to BSS0. Similarly, DHT was able to ameliorate cell
survival (p < 0.0001) and mitochondrial membrane potential
(p = 0.0016), diminished ROS levels (p < 0.0001 for both
DHE and DCFDA levels), and augmented NAO fluorescence
(p< 0.0005).
DISCUSSION
Previous evidence indicated that astrocytes play an important
role in maintaining neuronal homeostasis and that astrocytic
malfunctioning can severely impair neuronal metabolism and
survival (Cabezas et al., 2012, 2014, 2016; Posada-Duque et al.,
2014; Romero et al., 2014; Torrente et al., 2014). Therefore,
it is thought that protecting astrocytes function might be a
promissory strategy to promote neuronal survival following
various brain insults. In this study, we addressed whether
testosterone, an androgen with potent actions in the brain,
may protect mitochondria from astrocytes exposed to glucose
deprivation. Our results showed that testosterone increased
cell survival and reduced nuclear fragmentation and chromatin
condensation. These effects were accompanied by preservation
of mitochondrial function and an augmented expression of
neuroglobin.
Testosterone can induce different metabolic and genomic
responses in the brain. For example, it has been shown
that testosterone and its main metabolite, dihydrotestosterone,
reduced tissue damage and improved the outcome in an
in vivo model of focal ischemia (Cheng et al., 2009; Uchida
et al., 2009). Similarly, subcutaneous injection of testosterone
(1 mg/kg) reduced astrogliosis and microgliosis following a
stab wound injury in the brain (Barreto et al., 2007). The
neuroprotective mechanism is highly dependent on the dose
and a dosage to reach a more physiological concentration
(10 nM), exerts neuroprotective effects whereas a 10 times
higher dose of testosterone (100 nM) was not neuroprotective
(Orlando et al., 2007). This data is consistent with the findings
in the present study, where a pre-treatment with 10 nM
testosterone improved cell survival (Figure 1), assessed as a
decrease in PI staining (Figure 1). This effect can be mediated
by different mechanisms. For example, Gurer et al. (2015)
showed that testosterone reduced cell death by decreasing the
activity of caspase-3, a protease and main effector of different
apoptotic cascades. Also, Nguyen et al. (2005) showed that 10
nM testosterone increased the expression of protein kinases
ERK1/2, and Rsk-1, and inactivated pro-apoptotic proteins
such as Bad. In addition, testosterone can protect cells by
improving mitochondrial functions. For example, although there
are some conditions where ROS can be produced at low 1ψm,
pathophysiological levels of ROS are generally produced upon
high levels of mitochondrial membrane potential. It has been
shown that wherein 1ψm exceeds 140 mV (hyperpolarized
membrane), there is an exponential increase in ROS generation
in both mitochondrial complexes I and III (Liu, 1999). This
data is in agreement with the results presented in this study, in
which an exponential increase in H2O2 production was observed
after 6 h of GD, a time point in which the mitochondrial
membrane potential of cells T98G exposed to injury increased
by 64.2% in comparison to the levels found after 3 h of GD.
One explanation for this phenomenon is that cells may adapt
their mitochondria membrane potential according to the cellular
energy demands, regardless of whether this change may be
potentially deleterious for cell survival. Another interpretation
is that cells are experiencing apoptotic processes, specifically
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FIGURE 4 | Testosterone treatment preserves mitochondrial membrane potential in cells exposed for 18 h of glucose deprivation. The upper panel (A–C)
shows representative microphotographs of TMRM fluorescence in T98G cells exposed to BSS0 (A), BSS5 (B), and Testosterone + BSS0 (C). Scale bar 100 µm. The
bar graph shows the kinetics of mitochondrial membrane potential using flow cytometry of cells exposed to BSS0 only, or treated with 10 nM testosterone (D). Data
are represented as Mean ± SEM of 3 independent experiments. Mean ± SEM statistically significant values are as follows: 12 h, BSS5 (592.5 ± 13.03), BSS0 (238.7
± 21.83), Testosterone + BSS0 (519.6 ± 35.23); 18 h, BSS5 (317.5± 9.827), BSS0 (143.4 ± 11.37), Testosterone + BSS0 (275.1 ± 12.95), CCCP (106.00 ± 4.848).
mitochondrial damage, which is characterized by excessive
release of calcium, hyperpolarization of 1ψm, and an explosive
increase in the production of ROS (Kadenbach et al., 2004).
Although H2O2 is relatively less reactive, it can form different
hydroxy-reactive moieties in the presence of iron ions, which
can initiate cascades of oxidative stress such as lipid peroxidation
in the cell membrane. This oxidative stress is a key factor
in neurodegenerative diseases and one of its main causes
(Brand et al., 2004). Meanwhile, testosterone has shown to
have the ability to mitigate these oxidative stress processes by
reducing the levels of ROS, during injury caused by superoxide
(Tunez et al., 2007; Meydan et al., 2010; Gurer et al., 2015;
Xiao et al., 2015). This effect is consistent with the results
obtained, indicating that testosterone can reduce superoxide
levels in cells exposed to GD, possibly by mechanisms such
us the stimulation of the activity of the superoxide dismutase
(SOD; Li et al., 2006). Furthermore, it has been shown that
testosterone has the ability to reduce the levels of hydrogen
peroxide produced by GD in T98G cells. There is a clear
relationship of ROS production with 1ψm. For example, after
an increase of 1ψm, an increase in ROS production was
observed. Nevertheless, this increase in ROS, and membrane
hyperpolarization is not maintained over time during the insult,
likely because cellular energy levels significantly decrease, given
that cells exhaust its energy sources (glycogen and fatty acids
oxidation for example) for the production of ATP in the
early hours of the insult (Korenic et al., 2014). Likewise, it
is also possible that testosterone may inhibit mitochondria-
mediated apoptosis (Tunez et al., 2007; Vasconsuelo et al.,
2011; Gurer et al., 2015), since it has been shown that this
hormone induced the expression of the anti-apoptotic protein
Bcl-2 and reduced the pro-apoptotic protein Bax, in the cortex
and hippocampus of neonatal rats following ischemic damage (Li
et al., 2006).
Interestingly, we found that testosterone modulates the
expression of neuroglobin, a hemoprotein that is widely
expressed in neurons and in reactive astrocytes and reactive
microglia upon injury (DellaValle et al., 2010; Li et al.,
2014). Previous studies revealed that neuroglobin binds to
O2, is induced by hypoxia, and protects cell against death
caused by ischemia or hypoxia (Sun et al., 2001, 2003). Also,
neuroglobin improved mitochondrial permeability transition in
OGD (oxygen glucose deprivation) primary cortical neurons
(Yu et al., 2013a). The role of neuroglobin has been assessed
in different insults, in which one of these studies showed that
neuroglobin blockade worsened infarct volume and increased
ROS (Sun et al., 2003). This decrease in neuroglobin has
been also associated with an increased risk of developing
Alzheimer disease in humans (Szymanski et al., 2010). Among
the functions played by neuroglobin, it has been postulated
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FIGURE 5 | Testosterone preserves mitochondrial mass. The panel
shows representative microphotographs of NAO fluorescence in T98G cells
exposed to BSS0 (A), BSS5 (B), and Testosterone + BSS0 (C). Scale bar 100
µm. The bar graph shows the values of NAO fluorescence by flow cytometry,
and data are represented as Mean ± SEM of 3 independent experiments:
BSS0 (69.17 ± 3.489), Testosterone + BSS0 (87.53 ± 4.385) normalized
respect to BSS5.
FIGURE 6 | Testosterone induces the expression of neuroglobin in
T98G cells exposed to glucose deprivation. Representative
microphotographs of fluorescence of T98G cells exposed to BSS0 (A), BSS5
(B), and Testosterone + BSS0 (C). Scale bar 100µm. The bar graph shows
the values of neuroglobin mean fluorescence. Data are represented as Mean ±
SEM of 3 independent experiments. Mean ± SEM values are as follows: BSS5
(5320 ± 201.4), BSS0 (8814 ± 236.6), and Testosterone + BSS0 (10291 ±
208.9).
that this protein might help O2 transport, and may serve as a
sensor to hypoxia (Sun et al., 2003). Our findings demonstrate
a significant increased neuroglobin expression in cells exposed
to GD, which is consistent with the induction of this protein
when cells are exposed to different insults. Similarly, it is
observed that testosterone has an effect on the induction of
neuroglobin by increasing its expression when compared to
FIGURE 7 | Estradiol (Est) and DHT protect mitochondria in GD cells.
Estradiol and DHT, both metabolites of testosterone, were able to improve (A)
cell viability [87.95 ± 2.87 for Est and 76.07 ± 4.27 vs. BSS0 (57.08 ± 3.08)]
and (B) mitochondrial membrane potential [91.73 ± 6.09 for Est and 58.67 ±
3.68 for DHT vs. BSS0 (41.79 ± 5.10)], reduced (C) DHE fluorescence [175.6
± 9.0 for Est and 139.4 ± 5.10 for DHT vs. BSS0 (194.45 ± 4.37)] and (D)
H2O2 levels [59.83 ± 6.01 for Est and 42.27 ± 5.39 dor DHT vs. BSS0 (77.61
± 5.0)]. Additionally, estradiol and DHT also augmented (E) mitochondrial
mass [76.65 ± 2.94 for Est and 88.27 ± 3.57 for DHT vs. BSS0 (71.29 ±
3.12)], suggesting that testosterone protective effects on mitochondria might
be in part mediated by its metabolites.
levels of that from BSS0. This behavior suggests that testosterone
has the ability to induce expression of neuroprotective proteins
in damaging conditions. Given the different results described
above, it is suggested that the neuroprotective actions by
neuroglobin are specifically related to the maintenance of
ATP production and other mitochondrial functions (Yu et al.,
2013b), the elimination of ROS (Li et al., 2008a,b), and
the maintenance of the integrity of the cell membrane
(Antao et al., 2010). To determine whether testosterone
might exert protective actions on T98G cells through its
metabolites, we treated cells with estradiol or DHT. Interestingly,
both metabolites have shown to regulate cell survival and
improved mitochondrial functions in GD cells (Figure 7), thus
Frontiers in Aging Neuroscience | www.frontiersin.org 7 June 2016 | Volume 8 | Article 152
Toro-Urrego et al. Testosterone Protects Astrocytic cells
demonstrating that testosterone actions on T98G cells subjected
to glucose deprivation might be in part mediated by estradiol
and DHT.
In conclusion, our results demonstrate the protective
effects of testosterone in the astrocytic-like model
against GD induced cell death. Furthermore, testosterone
was shown to improve and preserve mitochondrial
functions and increase the expression of neuroglobin,
demonstrating a potential role in modulating ROS
production and inducing the expression of neuroprotective
proteins.
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